Emergent BioSolutions (EBS) Tops Q4 EPS by 46c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.95 +1.27%
Revenue Growth %: +32.0%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +32.0%
Financial Fact:
Total revenues: 142.91M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.05, $0.46 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $194.7 million versus the consensus estimate of $243.33 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump on Iran: we're trying to work out a deal that's fair
- Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%
- Tellus Power and Nayax partner on integrated EV charging platform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
